John Lane Bell
#11,538
Most Influential Person Now
Canadian mathematician and philosopher
John Lane Bell's AcademicInfluence.com Rankings
John Lane Bellphilosophy Degrees
Philosophy
#1061
World Rank
#2001
Historical Rank
Logic
#304
World Rank
#613
Historical Rank
Download Badge
Mathematics Philosophy
Why Is John Lane Bell Influential?
(Suggest an Edit or Addition)According to Wikipedia, John Lane Bell is an Anglo-Canadian philosopher, mathematician and logician. He is Professor Emeritus of Philosophy at the University of Western Ontario in Canada. His research includes such topics as set theory, model theory, lattice theory, modal logic, quantum logic, constructive mathematics, type theory, topos theory, infinitesimal analysis, spacetime theory, and the philosophy of mathematics. He is the author of more than 70 articles and of 13 books. In 2009, he was elected a Fellow of the Royal Society of Canada.
John Lane Bell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phenotypic Analysis of Antigen-Specific T Lymphocytes (1996) (3961)
- HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C (1998) (2125)
- HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus (1987) (1618)
- Association study designs for complex diseases (2001) (1520)
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. (1992) (1122)
- A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity (2005) (839)
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 (1996) (740)
- A molecular basis for MHC class II--associated autoimmunity. (1988) (678)
- HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. (1987) (563)
- A functional and structural basis for TCR cross-reactivity in multiple sclerosis (2002) (548)
- DNA repair is limiting for haematopoietic stem cells during ageing (2007) (520)
- Large clonal expansions of CD8+ T cells in acute infectious mononucleosis (1996) (515)
- Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors (2000) (476)
- Crystal structure of the complex between human CD8αα and HLA-A2 (1997) (409)
- Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility (1991) (386)
- Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease (1996) (372)
- HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. (1989) (370)
- Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. (1990) (344)
- TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL (1997) (341)
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis (2012) (332)
- A structural basis for immunodominant human T cell receptor recognition (2003) (332)
- TCR binding to peptide-MHC stabilizes a flexible recognition interface. (1999) (328)
- A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. (2001) (323)
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant (2021) (320)
- Factors influencing success of clinical genome sequencing across a broad spectrum of disorders (2015) (319)
- Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK (2021) (312)
- Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. (1991) (310)
- Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment (1995) (309)
- Identification and characterization of three members of the human SR family of pre‐mRNA splicing factors. (1995) (309)
- Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR (1993) (286)
- Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon (1995) (255)
- The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. (1993) (255)
- HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. (1996) (246)
- Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. (1992) (235)
- LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. (1997) (233)
- Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel (2020) (218)
- Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors (2000) (217)
- Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. (2002) (213)
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom (2021) (211)
- Human TCR-Binding Affinity is Governed by MHC Class Restriction1 (2007) (211)
- Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. (1998) (211)
- Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation (2021) (209)
- Predicting disease using genomics (2004) (207)
- Functional epistasis on a common MHC haplotype associated with multiple sclerosis (2006) (201)
- Allelic variation in the DR subregion of the human major histocompatibility complex. (1987) (199)
- T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. (1999) (198)
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom (2021) (196)
- HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. (1992) (191)
- Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis (2008) (185)
- Structure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐G (1998) (182)
- An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. (1996) (182)
- Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. (1996) (175)
- The human T cell receptor in health and disease. (1992) (174)
- The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain* (2001) (174)
- Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. (1995) (166)
- Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. (1998) (160)
- Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis (1986) (157)
- The value of animal models for drug development in multiple sclerosis. (2006) (155)
- Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity (2016) (154)
- HLA‐DR and HLA‐DP genotypes and immunoglobulin E responses to common major allergens (1994) (151)
- Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 (1996) (151)
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) (2021) (150)
- Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* (2000) (150)
- Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy (2004) (149)
- Suggestive Linkage of the Parathyroid Receptor Type 1 to Osteoporosis (1999) (143)
- Polygenic susceptibility in rheumatoid arthritis. (1991) (141)
- Missense glucokinase mutation in maturity–onset diabetes of the young and mutation screening in late–onset diabetes (1992) (136)
- Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK (2021) (135)
- Effect of heparin on polymerase chain reaction (1994) (133)
- Variation in human T cell receptor Vβ and Jβ repertoire: analysis using anchor polymerase chain reaction (1992) (129)
- Cytokine gene polymorphisms in autoimmune thyroid disease. (2000) (124)
- BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. (1999) (122)
- Conservation of T cell receptor usage by HLA B27‐restricted influenza‐specific cytotoxic T lymphocytes suggests a general pattern for antigen‐specific major histocompatibility complex class I‐restricted responses (1993) (121)
- HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVIS (1986) (120)
- Molecular coordination of αβ T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands (2002) (119)
- From genes to function: the next challenge to understanding multiple sclerosis (2009) (118)
- The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. (2008) (115)
- Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. (1995) (110)
- Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. (1997) (110)
- COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing (2021) (106)
- Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays (2020) (104)
- Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. (2006) (103)
- Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors (2004) (98)
- Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey (2020) (96)
- Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey (2020) (96)
- Characterization of the human T cell receptor α‐chain repertoire and demonstration of a genetic influence on Vα usage (1993) (95)
- Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden (2014) (95)
- Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. (1991) (91)
- Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines (2022) (91)
- A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. (2001) (86)
- A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. (1988) (83)
- Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease (2001) (83)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission (2021) (82)
- DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype. (1985) (82)
- The genetic contribution to human T-cell receptor repertoire. (1991) (81)
- Influence of Intron Length on Alternative Splicing of CD44 (1998) (79)
- Susceptibility loci in inflammatory bowel disease (1996) (77)
- Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease (1995) (74)
- Anti-spike antibody response to natural SARS-CoV-2 infection in the general population (2021) (69)
- Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis. (1988) (67)
- Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. (1991) (67)
- The genetics of inflammatory bowel disease. (1997) (66)
- Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor (1992) (65)
- Multiple origins of the sickle mutation: evidence from beta S globin gene cluster polymorphisms. (1983) (64)
- Community prevalence of SARS-CoV-2 in England during April to September 2020: Results from the ONS Coronavirus Infection Survey (2020) (63)
- Increased infections, but not viral burden, with a new SARS-CoV-2 variant (2021) (63)
- An immunohistological study of human lymphoma. (1980) (60)
- A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease? (1985) (60)
- Multiple DNA variant association analysis: application to the insulin gene region in type I diabetes. (1994) (59)
- Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK COVID-19 Infection Survey (2021) (56)
- Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. (1998) (54)
- Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta. (1987) (53)
- Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. (2004) (53)
- Crystal structure of HLA‐A*2402 complexed with a telomerase peptide (2006) (50)
- Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. (2002) (49)
- Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22 (1992) (49)
- Structure and Polymorphism of Murine and Human Class II Major Histocompatibility Antigens (1985) (49)
- The molecular basis of HLA-disease association. (1989) (47)
- Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time (2020) (47)
- Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction. (1992) (46)
- Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65‐kDa heat‐shock protein: Selective in vivo expansion of T cells bearing defined receptors (1993) (45)
- Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR (2020) (44)
- The double helix in clinical practice (2003) (44)
- Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping. (1992) (44)
- Production of soluble αβ T‐cell receptor heterodimers suitable for biophysical analysis of ligand binding (2008) (42)
- CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. (1994) (42)
- Antagonism of cytotoxic T-lymphocyte activation by soluble CD8 (1999) (42)
- Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele. (1991) (41)
- Chlamydial DNA is absent from the joints of patients with sexually acquired reactive arthritis. (1990) (41)
- Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive associations with HLA-DR4, DR1 and DRw10. (1991) (39)
- Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. (1994) (39)
- Expression of alternatively spliced forms of the CD44 extracellular‐matrix receptor on human lung carcinomas (1994) (39)
- Production and crystallization of MHC class I B allele single peptide complexes (1996) (38)
- Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli. (1994) (38)
- Erythrocytosis associated with a novel missense mutation in the BPGM gene (2010) (37)
- Sequence analysis of the human αβ T-cell receptor CDR3 region (2004) (37)
- Production, crystallization, and preliminary X‐ray analysis of the human MHC class Ib molecule HLA‐E (1998) (37)
- Direct ex vivo analysis reveals distinct phenotypic patterns of HIV‐specific CD8+ T lymphocyte activation in response to therapeutic manipulation of virus load (2001) (36)
- Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure (1995) (36)
- First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A*01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape1 (2007) (33)
- Genomewide association studies and common disease--realizing clinical utility. (2012) (33)
- HLA antigens and insulin-dependent diabetes (1988) (33)
- Maturity onset diabetes of the young is not linked to the insulin gene. (1983) (30)
- Reconstitution of antigen presentation in HLA class I‐negative cancer cells with peptide‐β2m fusion molecules (2001) (30)
- Comparative sequence analysis of the human T cell receptor TCRA and TCRB CDR3 regions. (1996) (30)
- Community prevalence of SARS-CoV-2 in England: Results from the ONS Coronavirus Infection Survey Pilot (2020) (30)
- The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom (2021) (30)
- Computational design and crystal structure of an enhanced affinity mutant human CD8 αα coreceptor (2007) (29)
- The association of HLA DR beta alleles with self-limiting and persistent forms of early symmetrical polyarthritis. (1993) (29)
- Genetics of inflammatory bowel disease. (1994) (29)
- Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants. (1992) (28)
- Single nucleotide polymorphisms and disease gene mapping (2002) (28)
- Molecular mapping class II polymoprhisms in the human major histocompatibility complex. II: DQβ (1987) (28)
- Two-Stage Genome-Wide Search in Inflammatory Bowel Disease: Strong Evidence for Susceptibility LOCI on Chromosomes 3, 7 and 12 (1997) (28)
- Viral load in community SARS-CoV-2 cases varies widely and temporally (2020) (27)
- Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom (2021) (27)
- Assembly and crystallization of the complex between the human T cell coreceptor CD8α homodimer and HLA‐A2 (1998) (27)
- TAP1 and TAP2 polymorphism in coeliac disease (2004) (27)
- An observational study of SARS-CoV-2 infectivity by viral load and 1 demographic factors and the utility lateral flow devices to prevent 2 transmission 3 4 (2021) (26)
- Clinical research is dead; long live clinical research (1999) (22)
- HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. (1992) (22)
- Novel CD8+ T Cell Antagonists Based on β2-Microglobulin* (2002) (20)
- Genetic factors as determinants of infectious disease transmission in human communities. (1988) (19)
- Sequence analysis of the human alpha beta T-cell receptor CDR3 region. (1995) (19)
- HLA typing by double ARMS (1991) (19)
- T cell receptor usage in autoimmune disease (2004) (18)
- HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes (2004) (18)
- A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions. (1993) (17)
- A new social contract for medical innovation (2015) (17)
- Analysis of a T-cell receptor V beta segment implicated in susceptibility to rheumatoid arthritis: V beta 2 germline polymorphism does not encode susceptibility. (1993) (16)
- Selection of T cell receptor variable gene‐encoded amino acids on the third binding site loop: a factor influencing variable chain selection in a T cell response (1995) (16)
- Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay (2020) (15)
- A locus telomeric toHLA-DPB encodes susceptibility to coeliac disease (2006) (15)
- HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification (2014) (15)
- Identification of Novel LNK Mutations In Patients with Chronic Myeloproliferative Neoplasms and Related Disorders (2010) (14)
- The immunogenetics of rheumatoid arthritis (2004) (14)
- A novel HLA-DR4 allele (DRB1*0414) in a patient with myasthenia gravis. (1992) (14)
- A functionally significant allelic polymorphism in a T cell receptor Vβ gene segment (1996) (14)
- Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide. (2005) (14)
- A functional CRISPR/Cas9 screen identifies kinases that modulate FGFR inhibitor response in gastric cancer (2019) (14)
- The structure of the human allo‐ligand HLA‐B*3501 in complex with a cytochrome p450 peptide: Steric hindrance influences TCR allo‐recognition (2006) (13)
- Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96. (2011) (13)
- Multiple sclerosis: MHC associations and therapeutic implications (2005) (13)
- A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis. (2013) (12)
- Impact of vaccination on new SARS-CoV-2 infections in the UK (2021) (12)
- Analysis of peptide‐binding motifs for two disease associated HLA‐DR13 alleles using an M13 phage display library (1996) (12)
- Weighing in on autoimmune disease: Big data tip the scale (2013) (11)
- HLA‐DR restriction‐fragment‐length polymorphisms in narcolepsy (1987) (11)
- Genetics of Inflammatory Bowel Disease. A Personal View on Progress and Prospects (1998) (10)
- Early Molecular Events in the Phytoalexin Defense Response (1983) (10)
- HLA‐DQ Restriction Fragment Length Polymorphisms in Myasthenia Gravis a (1987) (9)
- Polygenic disease. (1993) (9)
- Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide (1997) (9)
- Expression and function of HLA‐B27 in lipid‐linked form: Implications for cytotoxic T lymphocyte‐induced apoptosis signal transduction (1993) (9)
- Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance (2021) (9)
- Allelic polymorphism of human T-cell receptor V alpha gene segments (2004) (8)
- HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression (2015) (8)
- Structural and functional variability among DQβ alleles of DR2 subtypes (2004) (8)
- HLA B27: a disease-associated immune response gene. (1991) (8)
- HLA class II sequences infer mechanisms for major histocompatibility complex-associated disease susceptibility. (1989) (7)
- Globin gene mapping studies in Sardinian patients homozygous for beta zero Thalassaemia. (1983) (7)
- Computational design and crystal structure of an enhanced affinity mutant human CD8 alphaalpha coreceptor. (2007) (7)
- Molecular Structure of Human Class II Antigens (1989) (7)
- Medical implications of understanding complex disease traits. (1998) (6)
- Crystal structureof the complexbetweenhuman CD 8 aa andHLA-A 2 (1997) (6)
- Structural and functional variability among DQ beta alleles of DR2 subtypes. (1987) (6)
- Molecular anatomy of the immune response (1998) (6)
- The immunogenetic basis of autoimmunity. (1990) (5)
- Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta. (1987) (5)
- SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population (2021) (5)
- A call for advocacy and patient voice to eliminate hepatitis B virus infection. (2022) (4)
- Rapid HLA typing by multiplex amplification refractory mutation system. (1993) (4)
- T‐Cell Receptor Usage of Major Histocompatibility Complex Class I Restricted Peptide‐Specific T‐Lymphocytes (1995) (4)
- The major histocompatibility complex and disease. (1989) (4)
- Genetics of common disease: implications for therapy, screening and redefinition of disease. (1997) (4)
- Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population (2022) (4)
- Crystallization and preliminary X-ray structural studies of a high-affinity CD8αα co-receptor to pMHC (2005) (4)
- Anti-spike antibody response to natural SARS-CoV-2 infection in the general population (2021) (3)
- Molecular biology of the class II region of the human major histocompatibility complex. (1986) (3)
- Modelling the effectiveness and social costs of daily lateral flow antigen tests versus quarantine in preventing onward transmission of COVID-19 from traced contacts (2021) (3)
- Monitoring populations at increased risk for SARS-CoV-2 infection in the community (2021) (3)
- Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHC. (2005) (3)
- Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex. (2007) (3)
- Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom (2022) (3)
- Novel CD8+ T cell antagonists based on beta 2-microglobulin. (2002) (3)
- Detection of susceptability alleles to insulin-dependent diabetes mellitus at the DQB1 locus by artificial PCR-RFLP (2004) (3)
- Allele-specific DNA identity patterns (1987) (3)
- Refolding, crystallization and preliminary X-ray structural studies of the West Nile virus envelope (E) protein domain III. (2005) (3)
- THE GENOMIC ORGANIZATION OF THE HUMAN CD44 GENE (1993) (3)
- MORE MOLECULAR IMMUNOGENETICS (1989) (2)
- An immunofluorescent study of the ampicillin rash (1982) (2)
- Molecular aspects of autoimmunity: a review. (1992) (2)
- Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom (2021) (2)
- The HLA-DQB1 Gene Contributes to the Genetic Susceptibility to Insulin-Dependent Diabetes Mellitus (1989) (2)
- Host-targeting oral antiviral drugs to prevent pandemics (2022) (2)
- Does the locus on chromosome 11 implicated in susceptibility to HLA-DR4 dependent type I diabetes mellitus also affect susceptibility to rheumatoid arthritis? (1992) (1)
- Molecular Polymorphism of Human Immune-Response-Genes (1986) (1)
- Prenatal diagnosis: current status and future trends. (1990) (1)
- Monoclonal Antibody Definition of Polymorphism Within DRw52 (1989) (1)
- The molecular genetics of HLA-related disorders. (1987) (1)
- Structure of the CD4 gene and its expression during leucocyte activation (1993) (1)
- HLA-Ebindstonatural killer cell receptors CD 94 / NKG 2 A , BandC (1)
- PCR: A practical approach: edited by M.J. McPherson, P. Quirke and G.R. Taylor IRL Press at Oxford University Press, 1991. £19.50 (xxi + 253 pages) ISBN 0 19 963196 4 (1992) (1)
- United Kingdom . spondylitis in the white population in the HLA class I associations of ankylosing (1)
- T-CELL RECEPTOR USAGE OF SYNOVIAL LYMPHOCYTES FROM A PATIENT WITH REACTIVE ARTHRITIS (1992) (1)
- Susceptibility to type 1 diabetes mellitus and the insulin locus (1992) (1)
- Immunogenetics of endocrine disorders: edited by Nadir R. Farid, Alan R. Liss, Inc., 1988. $110.00 (xiii + 508 pages) ISBN 0 8451 4245 3 (1988) (1)
- New hope for haplotype mapping (2003) (1)
- HLA class II genes in ulcerative colitis: Strong evidence for a relationship between genotype and clinical phenotype (1995) (1)
- Class II Hla Genes in Inflammatory Bowel Disease: Evidence for a Relationship between Genotype and Disease Phenotype (1995) (1)
- Critical role for the Val / Gly 86 HLA-DR 8 dimorphism in autoantigen presentation to human T cells ( major histocompatibility complex / polymorphism / epitope presentation / acetylcholine receptor / myasthenia gravis ) (1)
- The challenge of limited vaccine supplies: impact of prior infection on anti-spike IgG antibody trajectories after a single COVID-19 vaccination (2021) (0)
- Insights into CTL Escape Immunogenic SIV Epitopes and Mamu-A*01 Complexed with Two MHC Class I: Crystal Structures of Presentation by Rhesus Macaque First Glimpse of the Peptide (2010) (0)
- HLA-B*27:05 presenting an HIV-1 14mer peptide (2021) (0)
- Insights Into Crossreactivity in Human Allorecognition: The Structure of HLA-B35011 Presenting an Epitope derived from Cytochrome P450. (2006) (0)
- Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients. (2018) (0)
- MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS (1993) (0)
- Abstract 3603: Megabase-scale determination of complex genetic aberrations of primary cancer genomes at individual DNA molecule resolution (2016) (0)
- Redirecting Polyclonal T Cells against Cancer with Soluble T-Cell Receptors (2022) (0)
- Strategies Finding IBD Genes (1999) (0)
- Abstract 2278: A high throughput method for the optimization of digital PCR assays for personalized circulating tumor DNA detection (2019) (0)
- carcinogenesis . the HLA associated risk of cervical Role of human papillomavirus in determining (0)
- Paul and Carol--2. More molecular immunogenetics. (1989) (0)
- DP ALLELES DO NOT INDEPENDENTLY CONFER SUSCEPTIBILITY TO CELIAC-DISEASE (1989) (0)
- Abstract 3232: Oligonucleotide-selective sequencing (OS-Seq): a rapid and efficient targeting technology for ultra-deep detection of cancer mutations and rearrangements. (2013) (0)
- HLA-B*27:05 presenting an HIV-1 6mer peptide (2021) (0)
- Fine specificity of an AChR-reactive T cell line from a young myasthenic patient (1991) (0)
- Crystal structure of HLA-DQ0602 in complex with a hypocretin peptide (2004) (0)
- X-ray crystal structure of HLA-DRA1*0101/DRB5*0101 complexed with a peptide from Epstein Barr Virus DNA polymerase (2002) (0)
- MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 (1998) (0)
- Epitope length variants balance protective immune responses and viral escape in HIV-1 infection (2022) (0)
- Recepteur de lymphocyte t soluble (1999) (0)
- Out of chains (1989) (0)
- THE T-CELL RECEPTOR V-BETA-2 SEGMENT CODING POLYMORPHISM IS NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA) (1993) (0)
- Distinguishing Healthy and Diseased Cells: MHC Class I Homologues and their Receptors (2003) (0)
- Abstract B6: Identification of novel mutations in the inhibitory adaptor protein LNK in patients with JAK2 V617F-negative and -positive chronic myeloproliferative neoplasms (2010) (0)
- A GENE INTERACTIVE WITH HLA-DR4 IN SUSCEPTIBILITY TO TYPE-I DIABETES IS NOT INVOLVED IN RHEUMATOID-ARTHRITIS (RA) (1992) (0)
- DETECTING t(14;18) IN PARAFFIN-EMBEDDED LYMPHOMA TISSUE (1989) (0)
- MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 (1998) (0)
- THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E (1999) (0)
- Contents Vol. 16, 1998 (1999) (0)
- Abstract 4871: A new multiple feature approach for rapid and highly accurate somatic structural variation discovery from whole cancer genome sequencing (2015) (0)
- CTL Escape InsightsTwo Immunogenic SIV Epitopes and Structures of Mamu-A * 01 Complexed with Rhesus Macaque MHC Class I : Crystal First Glimpse of the Peptide Presentation by and (2006) (0)
- Book Review Clinical Cancer Genetics: Risk counseling and management By Kenneth Offit. 419 pp. New York, John Wiley, 1998. $64.95. 0-471-14655-2 (1999) (0)
- HLA-B*27:05 presenting an HIV-1 7mer peptide (2021) (0)
- Longitudinal Analysis of Cytotoxic T Lymphocyte Responses and Viral Antigenic Diversification during Primary Hiv-1 Infection (1998) (0)
- Abstract PR02: Synthetic lethality screen identifies novel druggable targets in the MYC pathway (2017) (0)
- ULCERATIVE-COLITIS IS DIFFERENTIATED FROM OTHER COLONIC INFLAMMATION BY CD44-V3 AND CD44-V6 EXPRESSION (1995) (0)
- HLA-B*27:05 presenting an HIV-1 8mer peptide (2021) (0)
- HLA-DP LOCUS IN ATOPIC IGE RESPONSES (1993) (0)
- The Structure and Function of HLA-E (1999) (0)
- HLA-B*27:05 presenting an HIV-1 13mer peptide (2021) (0)
- HLA-DR HETEROZYGOSITY CONTRIBUTES SUSCEPTIBILITY TO SEVERE RHEUMATOID-ARTHRITIS (1992) (0)
- Abstract 5288: Dynamic genomic indexing enables accurate somatic variant detection from cancer genome sequencing without sequence alignment limitations (2016) (0)
- THE STRUCTURE OF THE GENE ENCODING THE ALTERNATIVELY SPLICED CD44 GLYCOPROTEIN (1993) (0)
- MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM (1998) (0)
- Governed by MHC Class Restriction Human TCR-Binding Affinity is (2010) (0)
- Improving the representativeness of UKs national COVID-19 Infection Survey through spatio-temporal regression and post-stratification (2023) (0)
- Genotypic and phenotypic approaches to pathways involved in humoral autoimmunity (2006) (0)
- T cell receptors. (1984) (0)
- B.ONGt*,N.WILLCOXt§, P.WORDSWORTH¶, D.BEESONt, A.VINCENTt, D.ALTMANNII, (1991) (0)
- Death Ligand TRAIL New Receptor Protecting Lymphocytes from the ( TNF-Related Apoptosis-Inducing Ligand ) : A Cutting Edge : Lymphocyte Inhibitor of TRAIL Screaton (1997) (0)
- Author response: Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time (2021) (0)
- HLA-B*27:05 presenting an HIV-1 11mer peptide (2021) (0)
- Abstract 1160: Whole genome amplification and high-throughput sequencing of formalin-fixed paraffin-embedded colorectal cancer (2010) (0)
- Outbreak of COVID-19 among vaccinated and unvaccinated homeless shelter residents- Sonoma County, California, July 2021 (2021) (0)
- SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection (2022) (0)
- Abstract 438: High-quality CNV segments from low-coverage whole genome sequencing from FFPE cancer biopsies based on an evaluation of multiple CNV tools (2018) (0)
- CONCISE REPORT Analyis of a T-cell receptor V,3 segment implicated in susceptibility to rheumatoid arthritis: V 2 germline polymorphism does not encode susceptibility (2004) (0)
This paper list is powered by the following services:
Other Resources About John Lane Bell
What Schools Are Affiliated With John Lane Bell?
John Lane Bell is affiliated with the following schools:
